Company Filing History:
1 out of 47 
1 out of 11 
1 out of 45 
Years Active: 2025
Title: Miguel Castanho: Innovator in Peptide Compounds
Introduction
Miguel Castanho is a notable inventor based in Lisbon, Portugal. He has made significant contributions to the field of medicinal chemistry, particularly in the development of peptide compounds aimed at reducing side effects associated with CB1 receptor agonists. His innovative work has the potential to impact therapeutic practices in various medical applications.
Latest Patents
Miguel Castanho holds a patent for peptide compounds designed to mitigate the side effects of CB1 receptor agonists. The patent details compounds of formula (I) or their pharmaceutically acceptable salts, along with processes for their obtention and therapeutic indications. This invention represents a significant advancement in the field of pharmacology.
Career Highlights
Throughout his career, Miguel has worked with prestigious institutions, including the Universitat de Barcelona and Universitat Pompeu Fabra. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.
Collaborations
Miguel has collaborated with notable colleagues such as Vicent Casadó Burillo and Estefania Moreno Guillen. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Miguel Castanho's work in peptide compounds exemplifies the innovative spirit of modern science. His contributions are paving the way for advancements in therapeutic applications, showcasing the importance of research and collaboration in the field of medicinal chemistry.